Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “medullary thyroid gland carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00416949
What this trial is testing

Iodine I 131 in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Not applicableActive Not RecruitingNCT04970134
What this trial is testing

Spanish Study for Molecular Characterization of Thyroid Carcinoma

Who this might be right for
Differentiated Thyroid CarcinomaMedullary Thyroid Carcinoma
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 150
Not applicableEnrolling By InvitationNCT07713901
What this trial is testing

Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma

Who this might be right for
Medullary Thyroid Carcinoma
Novo Nordisk A/S 93,600,000
Not applicableEnrolling By InvitationNCT06852144
What this trial is testing

PET-TC in Thyroid Evaluation

Who this might be right for
Medullary Thyroid CarcinomaHyperparathyroidismParathyroid Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 418
Testing effectiveness (Phase 2)Study completedNCT00004048
What this trial is testing

Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 30
Not applicableNot Yet RecruitingNCT07812779
What this trial is testing

Thyroid Health Outcomes Registry for Surgery

Who this might be right for
Thyroid DiseasesThyroid NeoplasmsThyroid Cancer+9 more
Pirogov Russian National Research Medical University 3,000
Not applicableNot Yet RecruitingNCT07048964
What this trial is testing

A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations

Who this might be right for
Medullary Thyroid Cancer (MTC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT00625846
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

Who this might be right for
Recurrent Thyroid Gland CarcinomaStage III Differentiated Thyroid Gland Carcinoma AJCC v7Stage III Thyroid Gland Medullary Carcinoma AJCC v7+10 more
National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Active Not RecruitingNCT06444880
What this trial is testing

Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies

Who this might be right for
SMARCB1-Deficient MalignanciesEpithelioid SarcomaRenal Medullary Carcinoma
M.D. Anderson Cancer Center 15
Not applicableNot Yet RecruitingNCT07621146
What this trial is testing

A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies

Who this might be right for
Neuroendocrine Tumors, NETPheochromocytoma/ParagangliomaSSTR-expressing Tumors+1 more
British Columbia Cancer Agency 51
Testing effectiveness (Phase 2)Study completedNCT00869050
What this trial is testing

Capecitabine and Temozolomide for Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Tumors
Columbia University 41
Not applicableStudy completedNCT02856347
What this trial is testing

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin

Who this might be right for
Medullary Thyroid Cancer
Institut Claudius Regaud 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Not applicableApproved For MarketingNCT03906331
What this trial is testing

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

Who this might be right for
Non Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+4 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Looking for participantsNCT06302569
What this trial is testing

Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma

Who this might be right for
Bellini CarcinomaCollecting Duct CarcinomaRenal Medullary Carcinoma
Giuseppe Procopio 23
Not applicableNo Longer AvailableNCT02174679
What this trial is testing

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Who this might be right for
Carcinoid CancerNeuroendocrine TumorsMedullary Thyroid Cancer+1 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT00027820
What this trial is testing

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 106
Early research (Phase 1)Not Yet RecruitingNCT07661420
What this trial is testing

211At-MABG in Adults With Advanced Neuroendocrine Cancers

Who this might be right for
PheochromocytomaParagangliomaNeuroendocrine Tumors+3 more
University of Pennsylvania 16
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Next Page